Lumenis Receives 2005 Technology Leadership Award from Frost & Sullivan

Yokneam, Israel, August 25, 2005 – Lumenis^® Ltd. (LUME.PK), a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, announced today that it is the recipient of the Frost & Sullivan 2005 Technology Leadership Award.

“We are proud to announce that Lumenis is the recipient of the 2005 Frost & Sullivan Technology Leadership Award. This recognition comes through stringent market analysis by our industry analysts,” commented Nathan Halabrin, Marketing Director of the Best Practices Group at Frost & Sullivan. “We present this award for Technology Leadership to Lumenis based on technological expertise, an extensive range of products and clinical applications in multiple markets, combined with continuous innovations that offer physicians precision, accuracy and customization. These are the driving forces that make Lumenis the 2005 Technology and World Market Leader in laser and light-based technologies,” concludes Frost & Sullivan Director of Healthcare, Monali Patel.

“We are very pleased to accept the prestigious 2005 Technology Leadership Award from Frost & Sullivan, recognizing Lumenis’ technology excellence and leadership,” comments Lumenis President and CEO, Avner Raz. “It is gratifying to know that independent experts studying this industry and the global markets in which we compete recognize the quality of our products as well as our constant focus on maintaining the leading edge in technology. Furthermore, it is truly a testament to the dedicated team at Lumenis who strive to deliver superior technology and support for clinicians and patients worldwide.”

Frost & Sullivan is a global growth consulting company and presents its Awards to companies demonstrating best practices in a variety of regional and global markets. These Awards recognize superior planning and execution of product launches, strategic alliances, distribution strategies, technological innovations, mergers and acquisitions and initial public offerings. Other critical marketing factors are also considered, such as leadership, strategy, service, innovation, integration and development. Frost & Sullivan was founded in 1961 and is recognized as a global marketing research and solution leader. For general information on the Frost & Sullivan Awards Program, log onto http://www.awards.frost.com.

Lumenis is a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis and its products, log onto www.lumenis.com.


Contact:

Lauri Hanover, CFO
1-866-232-6803
+972-4-959-9122

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties. The Company's actual results could differ materially from those anticipated in the forward looking statements based on a variety of factors, including, among others: uncertainties with respect to market acceptance of the Company's products, the implementation and outcome of its Turnaround Plan, obtaining regulatory approvals for new products or for the sale of existing products in new markets and enforcement of intellectual property rights; risks associated with competition and competitive pricing pressures, economic conditions generally, the Company's international operations and the Company's ability to integrate its operations with those of acquired businesses; the outcome of the Securities and Exchange Commission investigation and several securities class action lawsuits to which the Company is subject and the outcome of the investigation conducted by the Audit Committee; uncertainties relating to the Company’s continuing liquidity; and other risks detailed from time to time in the reports filed by Lumenis with the SEC, including its annual report on Form 10-K and quarterly reports on Form 10-Q.